Nuance Medical completed the acquisition of BIOCORNEUM, a
state-of-the-art silicone gel scar treatment brand, previously
owned by Sientra. Effective immediately, BIOCORNEUM will become a
part of the Biodermis portfolio, Nuance Medical's brand
specializing in silicone scar management products. This strategic
move enhances Biodermis' commitment to providing top-tier skin care
solutions to healthcare professionals.
CARLSBAD, Calif., April 18,
2024 /PRNewswire-PRWeb/ -- Nuance Medical, a leading
designer, developer, and marketer of branded and private label
medical products, announced today the successful acquisition of
BIOCORNEUM, a state-of-the-art silicone gel scar treatment brand,
previously owned by Sientra. Effective immediately, BIOCORNEUM will
become a part of the Biodermis portfolio, Nuance Medical's brand
specializing in silicone scar management products. This strategic
move enhances Biodermis' commitment to providing top-tier skin care
solutions to healthcare professionals.
"Bringing BIOCORNEUM into the Biodermis
family marks a significant step in our journey to lead with
innovative and impactful treatments in scar management."
Mark Steele, President of Nuance
Medical.
Recognized for over 30 years of innovation and effectiveness in
scar management, Biodermis has been at the forefront of
medical-grade silicone treatments for over three decades. Known for
its dedication to quality and innovation, Biodermis is a trusted
name among healthcare providers for effective, non-invasive scar
management solutions.
With the addition of BIOCORNEUM to Biodermis' extensive line of
scar management solutions, it ensures that the acclaimed properties
of BIOCORNEUM will continue under a brand that profoundly
understands the needs and expectations of healthcare professionals
and their patients.
"Bringing BIOCORNEUM into the Biodermis family marks a
significant step in our journey to lead with innovative and
impactful treatments in scar management," said Mark Steele, President of Nuance Medical. "This
acquisition integrates BIOCORNEUM's strong presence in the
professional healthcare sector with Biodermis' comprehensive range
of silicone scar management products. We are excited about the
combined capabilities this brings and the enhanced benefits it
offers to our healthcare partners and their patients."
In order to facilitate a smooth transition and continuous
support, BIOCORNEUM customers are asked to contact Biodermis
directly for placing orders or inquiries at 800.322.3729 or via
email at orders@biodermis.com. In addition, a dedicated webpage
with frequently asked questions for BIOCORNEUM customers can be
found at:
https://www.biodermis.com/pages/biocorneum-customer-faqs.
For further information on Biodermis, visit:
https://www.biodermis.com/.
About Biodermis
Biodermis, a brand under Nuance Medical, has been at the forefront
of medical-grade silicone treatments for over three decades. Known
for its dedication to quality and innovation, Biodermis is a
trusted name among healthcare providers for effective, non-invasive
scar management solutions.
About Nuance Medical
Headquartered in Carlsbad,
California, Nuance Medical is a leading designer, developer,
and marketer of branded and private label medical products. The
company, formed in 2013, develops innovative products for
underserved, niche markets in the healthcare sector. Nuance's
capabilities include product development, sales and marketing
expertise.
Media Contact
Natalie Mikolich, Nuance Medical,
5614144047, natalie@elementmagency.com,
https://www.nuancemedical.com/
View original content to download
multimedia:https://www.prweb.com/releases/nuance-medical-completes-acquisition-of-biocorneum-scar-treatment-brand-to-become-a-part-of-the-biodermis-portfolio-302120539.html
SOURCE Nuance Medical